Physician profile
Eileen C Comia
NPI 1235233313
$1,363.37
in general payments reported to CMS, 2019-2025
19 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $269 · 2021: $594 · 2022: $48.35 · 2023: $54.91 · 2024: $74.74 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $407.26 | 2019-2025 | |
| Pfizer INC. | $218.31 | 2019-2021 | |
| Amarin Pharma, INC. | $146.74 | 2020-2021 | |
| Exact Sciences Corporation | $90.73 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $78.73 | 2020-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.99 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $61.33 | 2019-2021 | |
| Allergan, INC. | $49.71 | 2019-2020 | |
| Lilly USA, LLC | $48.35 | 2022 | |
| Novo Nordisk INC | $34.03 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.01 | 2024 | Trintellix |
| Kowa Pharmaceuticals America, INC. | $21.65 | 2024 | Zoryve |
| Shield Therapeutics INC | $18.52 | 2023 | Accrufer |
| Abbott Laboratories | $17.86 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.63 | 2025 | Uptravi, Opsumit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.22 | 2019 | |
| Mylan Specialty L.P. | $13.74 | 2019 | |
| Ibsa Pharma INC. | $13.65 | 2023 | Tirosint, Licart |
| Teva Pharmaceuticals USA, INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Comia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.